Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.
Ferguson, A.D., McKeever, B.M., Xu, S., Wisniewski, D., Miller, D.K., Yamin, T.T., Spencer, R.H., Chu, L., Ujjainwalla, F., Cunningham, B.R., Evans, J.F., Becker, J.W.(2007) Science 317: 510-512
- PubMed: 17600184 
- DOI: https://doi.org/10.1126/science.1144346
- Primary Citation of Related Structures:  
2Q7M, 2Q7R - PubMed Abstract: 
Leukotrienes are proinflammatory products of arachidonic acid oxidation by 5-lipoxygenase that have been shown to be involved in respiratory and cardiovascular diseases. The integral membrane protein FLAP is essential for leukotriene biosynthesis. We describe the x-ray crystal structures of human FLAP in complex with two leukotriene biosynthesis inhibitors at 4.0 and 4.2 angstrom resolution, respectively. The structures show that inhibitors bind in membrane-embedded pockets of FLAP, which suggests how these inhibitors prevent arachidonic acid from binding to FLAP and subsequently being transferred to 5-lipoxygenase, thereby preventing leukotriene biosynthesis. This structural information provides a platform for the development of therapeutics for respiratory and cardiovascular diseases.
Organizational Affiliation: 
Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.